Furthermore, injection of PEGylated IL-10 into MMTV/HER2 transgenic mice led to tumor rejection that was dependent on activated CD8 T cells in an IFN-γ and Granzyme B-dependent manner [16]. The gene discussed is IL10; the disease is neoplasm.